PRA Health Sciences Inc. has been awarded the best contract research organisation (CRO) in Asia for the fourth time since 2013.
It received the recognition at the Phar-East Pharma and Biotech Festival (formally known as BioPharma Asia).
The award recognised the best CRO that has demonstrated an ongoing commitment to improving its clinical research services in Asia and in reducing lead times for its customers.
PRA has established a sophisticated infrastructure of in-house clinical research professionals throughout Asia Pacific, with more than 1,000 local clinical and project management staff, delivering comprehensive services in 12 countries.
Through PRA's strategic solutions division, the company also provides embedded solutions to integrate into the clients' internal clinical development operations, managing functions across the breadth of their development pipeline.
The solutions allow clients to maintain greater control over their clinical development processes while providing significant cost savings.
"PRA has continued to invest in the best talent and infrastructure globally and this includes Asia Pacific. I am extremely pleased that the team has been recognised and excited to continue building and investing to support clients and patients in the region," said its executive vice-president, Europe, Asia Pacific and Africa, David MacMurchy.
PRA has been strategically expanding its Asia Pacific operations since 2000 and has supported 345 clinical trials in the region at over 4,300 sites across Australia, China, Hong Kong, India, Japan, Malaysia, New Zealand, the Philippines, Singapore, South Korea, Taiwan and Thailand.